Држава: Арменија
Језик: Енглески
Извор: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
magnesium orotate (magnesium orotate dihydrate)
Mauermann-Arzneimittel KG
A12CC09
magnesium orotate (magnesium orotate dihydrate)
500mg
tablets
(20/2x10/) in blister, (50/5x10/) in blister
OTC
Registered
2022-06-10
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Magnerot Active ingredient: magnesium orotate dihydrate 500 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet contains: Active ingredient: 500 mg magnesium orotate dihydrate, corresponding to 2.7 mval, 1.35 mmol or 32.8 mg of magnesium Excipients with known effect: One tablet contains 50.0 mg lactose monohydrate and 2.5 mg sodium. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablets 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Magnesium deficiency 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The tablet should be swallowed whole with small amount of water before meals. 2 tablets 3 times a day for 7 days, then 1 tablet 2–3 times daily. The duration of treatment cycle is 4-6 weeks. If necessary, Magnerot can be used for a long time. In case of nocturnal leg cramps it is recommended to take 2-3 tablets in the evenings. 4.3 CONTRAINDICATIONS Increased sensitivity to ingredients of the medication, urinary stone disease, kidney failure, susceptibility to the formation of calcium-magnesium-ammonium-phosphate stones, liver cirrhosis with ascites. Children below 18 y.o. 4.4 SPECIAL WARNINGS AND PRECAUTIONS Magnerot contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine. Magnerot contains less than 1 mmol (23 mg) sodium per tablet, i.e. it is almost "sodium- free". With a maximum daily dose of 6 tablets, less than 23 mg sodium are supplied. Con- sideration should be given to patients on a sodium-restricted diet. 1 mmol of sodium (Na) = 23 mg Na = 58.4 mg salt (NaCl). Information relates to a thresold based on the total amount of sodium in the medicinal product. It is especially relevant to products used in children or in patients on a low sodium diet, to provide information to pre- scribers and reassurance to parents or patients concerning the low level of sodium in the product. Magnerot can be used fo Прочитајте комплетан документ